Bertinato Jesse
Nutrition Research Division, Bureau of Nutritional Sciences, Food Directorate, Health Products and Food Branch, Health Canada, Sir Frederick G. Banting Research Centre, Ottawa, ON, Canada; Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, ON, Canada.
Adv Food Nutr Res. 2021;96:365-415. doi: 10.1016/bs.afnr.2021.01.004. Epub 2021 Feb 24.
Iodine is an essential mineral nutrient and an integral component of thyroid hormones. Iodine deficiency is typically associated with goiter, but can have more serious health implications. Adequate iodine status is important for normal brain development. Iodine deficiency in utero or in early life can cause severe neurological and cognitive impairment. Over the last three decades, global efforts have reduced the prevalence of iodine deficiency disorders (IDD) in many areas of the world with implementation of nutrition policies and programs such as "salt" iodization. However, in a number of areas iodine deficiency is still widespread. Iodine deficiency in remote regions with high poverty will be more difficult to eradicate. Efforts to eliminate IDD in affected areas and sustaining successful iodine programs will be a priority given the substantial public health and economic benefits. A key component will be periodic monitoring of population iodine status to ensure sufficient intakes and the absence of excessive intakes. Median urinary iodine concentration (UIC), a validated biomarker for assessing population iodine status, will facilitate monitoring. Research validating "usual" UIC for use in combination with the Estimated Average Requirement cut-point method will expand its utility and allow accurate determination of the prevalence of inadequate intakes in populations. Further research on the development of biomarkers for assessment of individual iodine status for routine patient care will be important.
碘是一种必需的矿物质营养素,也是甲状腺激素的重要组成部分。碘缺乏通常与甲状腺肿大有关,但可能对健康产生更严重的影响。充足的碘状态对正常脑发育很重要。子宫内或生命早期的碘缺乏会导致严重的神经和认知障碍。在过去三十年中,通过实施“食盐”碘化等营养政策和计划,全球努力已降低了世界许多地区碘缺乏病(IDD)的患病率。然而,在一些地区,碘缺乏仍然普遍存在。贫困率高的偏远地区的碘缺乏将更难消除。鉴于巨大的公共卫生和经济效益,在受影响地区消除碘缺乏病并维持成功的碘计划将是优先事项。一个关键组成部分将是定期监测人群碘状态,以确保摄入充足且不过量。尿碘中位数浓度(UIC)是评估人群碘状态的有效生物标志物,将有助于监测。验证“常规”UIC以结合估计平均需求量切点法使用的研究将扩大其用途,并能准确确定人群中摄入不足的患病率。进一步开展关于开发用于常规患者护理的个体碘状态评估生物标志物的研究将很重要。